The Cigna Group (NYSE:CI – Get Free Report) insider Nicole S. Jones sold 4,904 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the sale, the insider now directly owns 29,421 shares of the company’s stock, valued at approximately $9,065,198.52. This trade represents a 14.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
The Cigna Group Trading Up 0.3 %
CI opened at $309.84 on Thursday. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The company has a fifty day moving average of $291.31 and a 200-day moving average of $318.05. The stock has a market cap of $86.18 billion, a PE ratio of 25.31, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54.
The Cigna Group (NYSE:CI – Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter last year, the firm earned $6.79 EPS. On average, sell-side analysts predict that The Cigna Group will post 29.77 EPS for the current year.
The Cigna Group Increases Dividend
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on CI. Cantor Fitzgerald lowered their price objective on shares of The Cigna Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Friday, January 31st. Royal Bank of Canada set a $355.00 price objective on shares of The Cigna Group in a research report on Friday, January 31st. Raymond James reiterated a “strong-buy” rating and set a $360.00 price objective (down from $415.00) on shares of The Cigna Group in a research report on Friday, January 31st. Stephens lowered their price objective on shares of The Cigna Group from $410.00 to $380.00 and set an “overweight” rating for the company in a research report on Friday, January 31st. Finally, Truist Financial lowered their price objective on shares of The Cigna Group from $390.00 to $375.00 and set a “buy” rating for the company in a research report on Tuesday, February 4th. Two research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, The Cigna Group has an average rating of “Buy” and a consensus price target of $372.31.
View Our Latest Analysis on CI
Institutional Investors Weigh In On The Cigna Group
Several large investors have recently modified their holdings of the company. Castle Rock Wealth Management LLC boosted its stake in The Cigna Group by 6.3% during the fourth quarter. Castle Rock Wealth Management LLC now owns 7,067 shares of the health services provider’s stock worth $2,066,000 after acquiring an additional 416 shares in the last quarter. Copley Financial Group Inc. boosted its stake in The Cigna Group by 7.8% during the fourth quarter. Copley Financial Group Inc. now owns 1,347 shares of the health services provider’s stock worth $372,000 after acquiring an additional 98 shares in the last quarter. Park Square Financial Group LLC bought a new position in The Cigna Group during the fourth quarter worth $62,000. Total Wealth Planning & Management Inc. bought a new position in The Cigna Group during the fourth quarter worth $402,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new position in The Cigna Group during the fourth quarter worth $77,488,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Stories
- Five stocks we like better than The Cigna Group
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- 3 Stocks to Consider Buying in October
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- 3 Warren Buffett Stocks to Buy Now
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.